A National Survey of Physician–Industry Relationships
Top Cited Papers
- 26 April 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (17) , 1742-1750
- https://doi.org/10.1056/nejmsa064508
Abstract
Relationships between physicians and pharmaceutical, medical device, and other medically related industries have received considerable attention in recent years. We surveyed physicians to collect information about their financial associations with industry and the factors that predict those associations. We conducted a national survey of 3167 physicians in six specialties (anesthesiology, cardiology, family practice, general surgery, internal medicine, and pediatrics) in late 2003 and early 2004. The raw response rate for this probability sample was 52%, and the weighted response rate was 58%. Most physicians (94%) reported some type of relationship with the pharmaceutical industry, and most of these relationships involved receiving food in the workplace (83%) or receiving drug samples (78%). More than one third of the respondents (35%) received reimbursement for costs associated with professional meetings or continuing medical education, and more than one quarter (28%) received payments for consulting, giving lectures, or enrolling patients in trials. Cardiologists were more than twice as likely as family practitioners to receive payments. Family practitioners met more frequently with industry representatives than did physicians in other specialties, and physicians in solo, two-person, or group practices met more frequently with industry representatives than did physicians practicing in hospitals and clinics. The results of this national survey indicate that relationships between physicians and industry are common and underscore the variation among such relationships according to specialty, practice type, and professional activities.Keywords
This publication has 13 references indexed in Scilit:
- On the TakePublished by Oxford University Press (OUP) ,2005
- Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal ProsecutionNew England Journal of Medicine, 2004
- Doctors and Drug CompaniesNew England Journal of Medicine, 2004
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: EntanglementBMJ, 2003
- Data Withholding in Academic GeneticsJAMA, 2002
- Industry Strongly Supports Continuing Medical EducationJAMA, 2001
- Uneasy Alliance — Clinical Investigators and the Pharmaceutical IndustryNew England Journal of Medicine, 2000
- Medical Professionalism — Focusing on the Real IssuesNew England Journal of Medicine, 2000
- Physicians and the Pharmaceutical IndustryJAMA, 2000
- Relationships between Academic Institutions and Industry in the Life Sciences — An Industry SurveyNew England Journal of Medicine, 1996